Acute febrile neutrophilic dermatosis is a rare inflammatory skin disorder characterized by a fever and a painful rash on the face, neck, arms, legs, and trunk. It is commonly known as the Sweet syndrome.
Sweet syndrome is classified into three categories: classical, malignancy-associated, and drug-induced. A classical sweet syndrome means that the disorder may be associated with other medical conditions such as respiratory infections, gastrointestinal infections, or pregnancy. Malignancy-associated refers to the appearance of Sweet syndrome together with specific kinds of cancer such as acute myeloid leukemia. A drug-induced Sweet syndrome is a reaction to taking certain drugs including granulocyte colony-stimulating factor (G-CSF), NSAIDS, and antibiotics, such as bactrim.
Corticosteroid medications are the most common method of treatment for Sweet syndrome. Signs and symptoms may disappear following treatment. However, there is a chance of recurrence if the underlying cause of Sweet syndrome is left unresolved.
Sweet syndrome can affect anyone. The symptoms may appear suddenly. They could last for weeks, months, or longer depending on the cause. The symptoms may include:
It is recommended to consult a doctor immediately if a rash is rapidly growing in size or symptoms are progressing.
The exact cause of Sweet syndrome is unknown. It may develop as a side effect of drug, most commonly a treatment that increases the production of white blood cells. It can be also associated with blood cancers or solid tumors, such as breast cancer or colon cancer.
Several factors may affect one’s risk of getting Sweet syndrome, such as:
No studies have shown that ethnicity affects one’s risk of developing Sweet syndrome.